We are live on ! Find out more
MD icon

Pediatrix Medical

304 hedge funds and large institutions have $5.49B invested in Pediatrix Medical in 2013 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 104 increasing their positions, 121 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 18

106% more call options, than puts

Call options by funds: $29M | Put options by funds: $14M

10% more funds holding

Funds holding: 276304 (+28)

9% more capital invested

Capital invested by funds: $5.05B → $5.49B (+$437M)

14% less repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 121

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

98.63% less ownership

Funds ownership: 201%102.38% (-99%)

Holders
304
Holders Change
+28
Holders Change %
+10.14%
% of All Funds
8.82%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.15%
New
48
Increased
104
Reduced
121
Closed
18
Calls
$29M
Puts
$14M
Net Calls
+$14.9M
Net Calls Change
+$19.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Comerica Bank
126
Comerica Bank
Texas
$4.23M -$189K -3,514 -4%
Two Sigma Investments
127
Two Sigma Investments
New York
$4.11M +$4.13M +77,024 New
MOACM
128
Mutual of America Capital Management
New York
$4.08M -$20.6K -384 -0.5%
ProShare Advisors
129
ProShare Advisors
Maryland
$4.01M +$3.41M +63,542 +547%
RHJA
130
Rice Hall James & Associates
California
$3.95M -$333K -6,202 -8%
ESCM
131
Echo Street Capital Management
New York
$3.93M +$3.95M +73,598 New
ASRS
132
Arizona State Retirement System
Arizona
$3.78M -$462K -8,600 -11%
Bank of Nova Scotia
133
Bank of Nova Scotia
Ontario, Canada
$3.74M +$3.76M +70,000 New
PPA
134
Parametric Portfolio Associates
Washington
$3.67M -$166K -3,086 -4%
DCM
135
Dupont Capital Management
Delaware
$3.61M -$1.36M -25,278 -27%
Macquarie Group
136
Macquarie Group
Australia
$3.53M -$1.64M -30,551 -32%
American Century Companies
137
American Century Companies
Missouri
$3.5M +$2.74M +51,047 +352%
Federated Hermes
138
Federated Hermes
Pennsylvania
$3.39M -$70.5K -1,313 -2%
Prudential Financial
139
Prudential Financial
New Jersey
$3.34M -$279K -5,200 -8%
Citigroup
140
Citigroup
New York
$3.26M +$2.98M +55,615 +1,033%
BG
141
BlackRock Group
United Kingdom
$3.15M +$148K +2,767 +5%
US Bancorp
142
US Bancorp
Minnesota
$3.03M -$411K -7,661 -12%
DCM
143
Daruma Capital Management
New York
$2.96M -$17.8K -332 -0.6%
KCM
144
Kennedy Capital Management
Missouri
$2.91M +$58.9K +1,098 +2%
MFIMFI
145
Mesirow Financial Investment Management - Fixed Income
Illinois
$2.89M +$144K +2,676 +5%
SFU
146
Stonehage Fleming (UK)
United Kingdom
$2.86M +$2.88M +53,600 New
Nomura Holdings
147
Nomura Holdings
Japan
$2.84M +$2.57M +47,943 +897%
AQR Capital Management
148
AQR Capital Management
Connecticut
$2.73M +$2.18M +40,700 +386%
CCIA
149
Campbell & Co Investment Adviser
Maryland
$2.63M +$2.65M +49,301 New
MSA
150
Mason Street Advisors
Wisconsin
$2.54M -$31.2K -581 -1%

MD Hedge Fund Activity: Q4 2013 in Review

304 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2013, worth a combined $5.49B — up 8.7% from $5.05B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new MD positions and 18 closed out — a net gain of 30 holders — while 104 added to existing stakes and 121 trimmed.

The largest buyer was EARNEST Partners, opening a new position worth an estimated $134M. The largest seller was Fidelity Investments, cutting an estimated $57.1M.

  • 304 institutional investors held Pediatrix Medical (MD) as of Q4 2013, up from 276 in Q3 2013.
  • Funds reported $5.49B of Pediatrix Medical stock for Q4 2013, up 8.7% quarter-over-quarter.
  • 48 funds opened new Pediatrix Medical positions in Q4 2013 and 18 closed out, a net change of +30 holders.
  • The largest Pediatrix Medical buyer in Q4 2013 was EARNEST Partners, an estimated $134M added.
  • The largest Pediatrix Medical seller in Q4 2013 was Fidelity Investments, an estimated $57.1M sold.

Based on aggregated 13F filings for Q4 2013.